By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Versartis, Inc.  

4200 Bohannon Drive
Suite 250
Menlo Park  California  94025  U.S.A.
Phone: 650-963-8588 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Bay Area's Versartis (VSAR) Strikes $165 Million Growth Hormone Deal With Teijin Limited 8/10/2016 8:42:51 AM
Versartis, Inc. (VSAR) Presents Confirmatory 18-Month Adherence Data From Ongoing Somavaratan Extension Study At Late-Breaker Session At ENDO Annual Meeting 4/1/2016 8:04:15 AM
Versartis, Inc. (VSAR) To Present At The Cowen and Company 36th Annual Health Care Conference 3/2/2016 8:18:23 AM
Versartis, Inc. (VSAR) Reports Confirmatory Top-Line Two-Year Data From Ongoing Extension Study Of Somavaratan In GHD Children 2/2/2016 7:52:28 AM
Versartis, Inc. (VSAR) To Present At The Credit Suisse 24th Annual Healthcare Conference 11/4/2015 8:11:56 AM
Versartis, Inc. (VSAR) Reports Third Quarter 2015 Financial Results 10/30/2015 8:06:14 AM
Versartis, Inc. (VSAR) Presents Confirmatory 18-Month Data From Ongoing Somavaratan Extension Study At Late-Breaker Session At ESPE Annual Meeting 10/1/2015 7:59:31 AM
Versartis, Inc. (VSAR) Announces Confirmatory 18-Month Data From Ongoing Extension Study Of Somavaratan In GHD Children 9/18/2015 6:21:01 AM
Versartis, Inc. (VSAR) Appoints Lars Ekman, MD, PhD, As Global Development Advisor 9/10/2015 7:48:52 AM
Versartis, Inc. (VSAR) Initiates Phase II Trial (VITAL) Of Monthly Somavaratan In Adults With Growth Hormone Deficiency 9/10/2015 7:28:12 AM
123456789
//-->